Option to Manufacture Sample Clauses

Option to Manufacture. 9.1 In the event that Orchid decides to engage a third party to manufacture Kits for it, Orchid will notify NEN and afford NEN the opportunity to make an offer to manufacture Kits for Orchid. At the same time Orchid may solicit and entertain offers from third parties for the manufacture of Kits. However, Orchid may not accept any third- party offer until thirty (30) days after it offers the same terms and conditions as the third-party offer to NEN and NEN has not accepted such terms and conditions. The option and rights provided by this paragraph are personal to NEN and may not be sub-licensed or otherwise transferred without the prior express written approval of Orchid.
Sample 1Sample 2
AutoNDA by SimpleDocs
Option to Manufacture. IDDS hereby grants to West an option to first negotiate with IDDS for the right to manufacture and/or package commercial quantities of the Licensed Product (the "Manufacturing Rights Option"), as follows:
Sample 1Sample 2
Option to Manufacture. In the event that for any reason (other than by a Force Majeure Act, as defined in Section 15.10), (i) Cygnus is unable to supply on a timely basis at least seventy-five percent (75%) of the volume of all-ordered Product during a Calendar Quarter and (ii) such orders are not greater than the forecasted Product requirements included in the then current Sales, Marketing and Distribution Plan, then the Term will be extended for twice the number of days Cygnus is unable to supply on a timely basis at least seventy-five percent (75%) of the volume of all-ordered Product. In the event that the failure to supply continues for six (6) months, then Sankyo has the option, at its sole discretion, to either terminate this Agreement pursuant to Section 11.4 or exercise its right to manufacture or have manufactured the Product for sale in the Territory during the Term pursuant to Section 2.1. From time to time, the parties will exchange information relating to orders, inventory levels and backlog.
Sample 1Sample 2
Option to Manufacture. For a period of five (5) years after the Effective --------------------- Date, HUS shall have the option to have ATL manufacture Products for HUS under the terms of this Agreement (the "Option").
Sample 1
Option to Manufacture. To the extent that TWAgbio intends to have Finished Products or Cleavase Enzyme manufactured by a third party in accordance with this Agreement, TWAgbio shall first notify TWT in writing of its intent to do so and, at TWT's request, negotiate with TWT the possibility of a right for TWT to supply the same. The foregoing sentence shall not apply to TWAgbio's exercise of its right to have Finished Products or Cleavase Enzyme manufactured pursuant to Section 7.2.9 as a result of TWT's failure to supply quantities ordered by TWAgbio in accordance with Article 7 above.
Sample 1
Option to Manufacture. Notwithstanding anything to the contrary herein, Can-Fxxx hereby grants SKK an option to manufacture or have a Third Party manufacture on SKK’s behalf (provided such Third Party contract manufacturer is approved in advance by Can-Fxxx, such approval not to be unreasonably withheld or delayed) the Ingredient solely for incorporation into the Product for development hereunder and/or for Product sale, promotion, distribution, use and other commercial purposes in the Field in the Territory.
Sample 1
Option to Manufacture. In the event that for any reason (other than by a Force Majeure Act, as defined in Section 15.10), (i) Cygnus is unable to supply on a timely basis at least [CONFIDENTIAL TREATMENT REQUESTED BY CYGNUS, INC.] of the volume of all-ordered Product during a Calendar Quarter and (ii) such orders are not greater than the forecasted Product requirements included in the then current Sales, Marketing and Distribution Plan, then the Term will be extended for twice the number of days Cygnus is unable to supply on a timely basis at least [CONFIDENTIAL TREATMENT REQUESTED BY CYGNUS, INC.] of the volume of all-ordered Product. In the event that the failure to supply continues for [CONFIDENTIAL TREATMENT REQUESTED BY CYGNUS, INC.] , then Sankyo has the option, at its sole discretion, to either terminate this Agreement pursuant to Section 11.4 or exercise its right to manufacture or have manufactured the Product for sale in the Territory during the Term pursuant to Section 2.1. From time to time, the parties will exchange information relating to orders, inventory levels and backlog.
Sample 1
AutoNDA by SimpleDocs
Option to Manufacture. 1. If, over any calendar year (the "Base Year") both (a) and (b) are true:
Sample 1

Related to Option to Manufacture

  • Manufacture (a) Manufacturer shall only manufacture the specific number of Products as requested by Company and at no time shall manufacture excess goods or overruns. Manufacturer shall not sell any Products bearing the Trademarks to any third parties without the express written consent of Company.

  • Supply of Materials Unless the parties otherwise agree in a Work Order, Manufacturer will supply, in accordance with the relevant approved raw material specifications, all materials to be used by Manufacturer in the performance of Services under a Work Order other than the Rhythm Materials specified in such Work Order. Rhythm or its designees will provide Manufacturer with the Rhythm Materials. Manufacturer agrees (a) to account for all Rhythm Materials, (b) not to provide Rhythm Materials to any third party (other than an Affiliate acting as a permitted subcontractor) without the express prior written consent of Rhythm, (c) not to use Rhythm Materials for any purpose other than conducting the Services, including, without limitation, not to analyze, characterize, modify or reverse engineer any Rhythm Materials or take any action to determine the structure or composition of any Rhythm Materials unless required * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. pursuant to a signed Work Order, and (d) to destroy or return to Rhythm all unused quantities of Rhythm Materials according to Rhythm’s written directions.

  • Manufacture of Products All Products marketed through Grantor's Web ------------------------- Site shall be manufactured, packaged, prepared, and shipped in accordance with the specifications and requirements described on Exhibit A hereto as it may be modified from time to time. Quality control standards relating to the Product's weight, color, consistency, micro-biological content, labeling and packaging are also set forth on Exhibit A. In the event that Exhibit A is incomplete, Products shall be manufactured and shipped in accordance with industry standards.

  • Manufacture of Product Prior to commercialization of the Product, the Parties may, if appropriate for both parties, negotiate in good faith a manufacturing and supply agreement to provide for Licensor to fulfill the manufacturing requirements of Licensee for Product for sale in the European market. The cost of such manufacturing shall not be greater than * percent (*%) of the cost of any competitor cGMP contract manufacturing facility that proposes to manufacturer the Product for Licensee. * Confidential information has been omitted and filed confidentially with the Securities and Exchange Commission.

  • Supply of Product The JDC shall be responsible for determining the sources of, and arrangements for, the manufacture and supply of Products that the JDC believes will result in long-term profit maximization for such Products. The JDC shall endeavor to [ * ].

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Supply of Products TheraSense shall be responsible for the ------------------ manufacture of FreeStyle Products for sale to Nipro.

  • API A. Reliant shall supply to Cardinal Health for Manufacturing and Packaging, at Reliant’s sole cost, the API and applicable reference standards in quantities sufficient to meet Reliant’s requirements for each Product as further set forth in Article 4. Prior to delivery of any of the API or reference standard to Cardinal Health for Manufacturing and Packaging, Reliant shall provide to Cardinal Health a copy of the API Material Safety Data Sheet (“MSDS”), as amended, and any subsequent revisions thereto. Reliant shall supply the API, reference standards, and Certificate of Analysis FOB the Facility no later than thirty (30) days before the scheduled Manufacture Date upon which such API will be used by Cardinal Health. Upon receipt of the API, Cardinal Health shall conduct identification testing of the API. Cardinal Health shall use the API solely and exclusively for Manufacturing and Packaging under this Agreement. The maximum volume of API that Reliant supplies to Cardinal Health shall not exceed the amount reflected in the Firm Commitment and the next six (6) months of the Rolling Forecast.

  • Product The term “

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

Time is Money Join Law Insider Premium to draft better contracts faster.